Newsroom | 3126 results

Sorted by: Latest

Baby/Maternity
-

Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of RSV in Infants During Their First RSV Season...
-

Dental.com Partners With Firstgrin to Bring Parents 24/7 Access to Virtual Dental Care for Newborns

IRVINE, Calif.--(BUSINESS WIRE)--Dental.com Partners With Firstgrin to Bring Parents 24/7 Access to Virtual Dental Care for Newborns...
-

Beverly Hills Honors Reproductive Partners Medical Group for Leadership in Men’s Fertility Health

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--In recognition of men’s reproductive wellness, the City of Beverly Hills has joined Reproductive Partners Medical Group in establishing September 17, 2025, as Men’s Fertility Health Day. The certificate of recognition, issued by Mayor Dr. Sharona Nazarian, highlights RPMG’s efforts to elevate awareness and break long-standing stigmas around male reproductive health. “Male fertility has been under-discussed, underdiagnosed, and underserved,” said Dr. James...
-

ByHeart Debuts its “Best for Breastfed Babies” Infant Formula at SamsClub.com in Exclusive 2-Pack

NEW YORK--(BUSINESS WIRE)--ByHeart, the next-generation infant nutrition company, today announced its debut on SamsClub.com with an exclusive 2-pack, becoming the only baby formula brand available on Sam’s Club’s digital shelves to combine a closest-to-breast-milk patented protein blend with both clinical validation2 and certified clean ingredients.3 Already available in nearly 12,000 retail locations nationwide, including Walmart, Target, Whole Foods, and Kroger, ByHeart’s arrival at Sam’s Clu...
-

Fit Minded Sets a New Standard for Digital Health Evidence

PHOENIX--(BUSINESS WIRE)--Fit Minded, the strategic applied science firm founded by former Calm Head of Science, Dr. Jennifer Huberty, today released Closing the Proof Gap, a white paper showing how digital health companies turn science into business momentum. It distills nearly 40 peer-reviewed studies and dozens of insights informing product strategy, payer conversations, and investor traction. As digital health innovation accelerates, the gap between promise and proof has become a growth bar...
-

Publix Charities Donates $15 Million to Help People Facing Food Insecurity

LAKELAND, Fla.--(BUSINESS WIRE)--Publix, its associates and Publix Super Markets Charities (PSMC) are working together during Hunger Action Month to address food insecurity in the company’s operating area. PSMC is donating $15 million to more than 400 local food banks and other nonprofit organizations, including 40 Feeding America® partner food banks. These funds will help support initiatives like weekend backpack programs, food pantries and meal delivery services. A portion of the donation wil...
-

Prota Therapeutics Announces PRT120 Follow-on Study Awarded EAACI Prize for Long-Term Post-Treatment Data Demonstrating Durable Remission Following 18 months of PRT120 Peanut Oral Immunotherapy

MELBOURNE, Australia--(BUSINESS WIRE)--Prota Therapeutics Pty Ltd (“Prota”), a clinical-stage biotechnology company focused on the development of novel oral immunotherapy treatments that induce remission of allergy, today announced clinical research conducted in partnership with Murdoch Children’s Research Institute (MCRI) and presented at the 2025 European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress was awarded an EAACI Prize for outstanding oral abstract presentation. T...
-

Novocuff Announces IDE Approval for the RETAIN Study

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Novocuff, Inc., a clinical-stage, maternal health medical device company, today announced approval from the U.S. Food and Drug Administration of its Investigational Device Exemption (IDE) application for the RETAIN Study. The study is a randomized, multicenter, pivotal trial evaluating the Novocuff Cervical Control System™ (CCS). The RETAIN study evaluates the safety and effectiveness of the Novocuff CCS, a medical device intended to retain amniotic fluid...
-

Materna Medical Announces New Case Series Highlighting Long-Term Persistence of Pelvic Floor Injuries Following Vaginal Delivery

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Materna Medical, a women’s health company pioneering solutions to protect and restore pelvic floor health, announced the presentation of a new case series at the 2025 Society of Ob/Gyn Hospitalists (SOGH) Annual Clinical Meeting, which provides long-term follow-up data confirming the persistence of levator ani muscle avulsions and highlights the risk reduction potential of the Ellora™ Obstetrical System. Dr. Helai Hesham of Columbia University Irving Medi...
-

Munchkin Named a Finalist in Fast Company’s 2025 Innovation by Design Awards

LOS ANGELES--(BUSINESS WIRE)--Munchkin Inc. (“Munchkin”), the beloved baby lifestyle company owned by WHY Brands, Inc. (“WHY”), today announced its recognition on Fast Company’s Innovation by Design list for the debut of Flow Nipple Shield + (“Flow”), the world’s first nipple shield that lets mothers see their milk flow to their baby while nursing. The list celebrates designers and businesses addressing today’s most urgent challenges while anticipating the issues that will shape tomorrow. Now i...